Skip to main content
Log in

Innovating TACE to Keep Up with the Rapidly Changing Field of Oncology

  • Commentary
  • Commentary
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Golfieri R, Bezzi M, Verset G. Retrospective European multicentric evaluation of selective transarterial chemoembolisation with and without balloon-occlusion in patients with hepatocellular carcinoma: a propensity score matched analysis. Cardiovasc Interv Radiol. 2021. https://doi.org/10.1007/s00270-021-02805-5.

    Article  Google Scholar 

  2. Gardini AC, Tamburini E, Iñarrairaegui M, Frassineti GL, Sangro B. Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials. Onco Targets Ther. 2018;11:7315–21.

    Article  CAS  Google Scholar 

  3. Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim T-Y, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382:1894–905.

    Article  CAS  Google Scholar 

  4. van Roekel C, van den Hoven AF, Bastiaannet R, Bruijnen RCG, Braat AJAT, de Keizer B, et al. Use of an anti-reflux catheter to improve tumor targeting for holmium-166 radioembolization—a prospective, within-patient randomized study. Eur J Nucl Med Mol Imaging. European Journal of Nuclear Medicine and Molecular Imaging; 2020;166.

Download references

Funding

This study was not supported by any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maarten L. J. Smits.

Ethics declarations

Conflict of interest

MS has received a speaker honorarium from BTG and Terumo. The Department of Radiology and Nuclear Medicine of the UMC Utrecht receives royalties from Quirem Medical and research support from Boston Scientific, Terumo, and Quirem Medical.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

For this type of study, informed consent is not required.

Consent for Publication

For this type of study, consent for publication is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smits, M.L.J. Innovating TACE to Keep Up with the Rapidly Changing Field of Oncology. Cardiovasc Intervent Radiol 44, 1681–1682 (2021). https://doi.org/10.1007/s00270-021-02823-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-021-02823-3

Navigation